Wang M - Search Results

1

Clinical features and outcomes of ALK rearranged non-small cell lung cancer with primary resistance to crizotinib.

Ma D, Zhang Y, Xing P, Hao X, Wang M, Wang Y, Shan L, Xin T, Liang H, Du Y, Zhang Z, Liang L, Li J. Ma D, et al. Among authors: wang y, wang m. Thorac Cancer. 2019 May;10(5):1213-1219. doi: 10.1111/1759-7714.13071. Epub 2019 Apr 16. Thorac Cancer. 2019. PMID: 30993895 Free PMC article.

2

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ. Mu XL, et al. BMC Cancer. 2004 Aug 19;4:51. doi: 10.1186/1471-2407-4-51. BMC Cancer. 2004. PMID: 15318946 Free PMC article. Clinical Trial.

3

[Treatment of non-small cell lung cancer with gefitinib].

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ. Zhang XT, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Mar;28(3):180-3. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854414 Chinese.

4

Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ, Song W. Zhang XT, et al. Chin Med J (Engl). 2005 Oct 5;118(19):1661-4. Chin Med J (Engl). 2005. PMID: 16232354 No abstract available.

5

Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L. Wang MZ, et al. Chin Med J (Engl). 2006 Jan 5;119(1):63-8. Chin Med J (Engl). 2006. PMID: 16454984 No abstract available.

6

[Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer].

Zhang L, Wang SL, Zhang XT, Li LY, Wang MZ. Zhang L, et al. Zhonghua Nei Ke Za Zhi. 2007 May;46(5):392-5. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637309 Chinese.

7

[Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].

Wu C, Li LY, Wang MZ, Zhang L, Zhang XT, Zhong W, Wang SL, Wang HZ. Wu C, et al. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):943-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478938 Clinical Trial. Chinese.

8

[Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].

Wang MZ, Zhong W, Zhang L, Li LY, Wang SL, Li JR, Zhang XT. Wang MZ, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):221-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756941 Clinical Trial. Chinese.

9

[Evaluation of efficacy and safety of ZD1839 as monotherapy in Chinese patients with advanced non-small cell lung cancer].

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L, Li JR. Wang MZ, et al. Zhonghua Nei Ke Za Zhi. 2008 Apr;47(4):291-5. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18843952 Chinese.

10

[The efficacy and safety of pemetrexed as monotherapy for Chinese patients with advanced non-small cell lung cancer].

Zhong W, Zhao J, Zhang XT, Zhang L, Wang MZ, Li LY. Zhong W, et al. Zhonghua Nei Ke Za Zhi. 2010 Aug;49(8):671-4. Zhonghua Nei Ke Za Zhi. 2010. PMID: 20979786 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,450 results

Search Page

Filters